Care

The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.

Also: Butterfly Network reports a year-over-year revenue increase of more than 25%, with a $44.5 million net loss, and One Medical announces a significant jump in revenue.

Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.

The round included a strategic investment from pharma giant Gilead Sciences to expand their partnership for decentralized and hybrid trials.

The firm plans to expand its chronic disease treatments across more therapeutic areas.

Also: Pediatric behavioral health company Brightline partners with a youth health education nonprofit to develop teen programs, and digital fitness startup FitOn launches courses for seniors and people with chronic conditions.

The suspension comes as the digital mental health company faces increasing pressure over its prescription practices, particularly for ADHD medications.

Also: Imagene AI raises $21.5 million across two rounds for precision cancer care, and Capable Health scores $6 million in seed funding to help providers build healthcare apps.

The completed deal comes weeks after LetsGetChecked announced its intent to acquire Veritas Genetics and Veritas Intercontinental.

The AI tech can spot signs of pancreatic cancer from non-contrast CT images.